International AIDS Vaccine Initiative:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:International AIDS Vaccine Initiative - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9306
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
International AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, discovery, preclinical evaluation and manufacturing, and regulatory review, among others. Its products include mRNA-NFL, BG505 Envelope, eOD Immunogen, AAV-PG9, AD26, MVA, protein and CDV replicating vector, among others. IAVI conducts vaccine trials and related epidemiological research in partnership with academic, biotechnology, pharmaceutical and governmental institutions. The organization partners with government agencies, civil society, clinical, research institutions. It has operations across South Africa, Kenya, India, the US, and the Netherlands. IAVI is headquartered in New York, the US.

International AIDS Vaccine Initiative – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
International AIDS Vaccine Initiative Acquires Clinical Programs and Assets from Aeras TB Vaccine 10
Partnerships 11
IAVI and Serum Institute of India Enter into Development Partnership 11
International AIDS Vaccine Partners with CureVac 12
IAVI, GlycoMimetics, And Glycosensors and Diagnostics Enter Into Agreement To Develop AIDS Vaccine 13
Licensing Agreements 14
Valneva Enters Into Licensing Agreement With International AIDS Vaccine Initiative For HIV Vaccine 14
International AIDS Vaccine Initiative – Key Competitors 15
International AIDS Vaccine Initiative – Key Employees 16
International AIDS Vaccine Initiative – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Product News 18
05/31/2018: IAVI, Selexis SA and Collaborators Publish Study Highlighting Improved Approach for Generating Complex Proteins Required for Producing HIV Vaccines 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Key Facts 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International AIDS Vaccine Initiative, Deals By Therapy Area, 2012 to YTD 2018 8
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International AIDS Vaccine Initiative Acquires Clinical Programs and Assets from Aeras TB Vaccine 10
IAVI and Serum Institute of India Enter into Development Partnership 11
International AIDS Vaccine Partners with CureVac 12
IAVI, GlycoMimetics, And Glycosensors and Diagnostics Enter Into Agreement To Develop AIDS Vaccine 13
Valneva Enters Into Licensing Agreement With International AIDS Vaccine Initiative For HIV Vaccine 14
International AIDS Vaccine Initiative, Key Competitors 15
International AIDS Vaccine Initiative, Key Employees 16
International AIDS Vaccine Initiative, Other Locations 17

List of Figures
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International AIDS Vaccine Initiative, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[International AIDS Vaccine Initiative:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sensus USA Inc:企業の戦略的SWOT分析
    Sensus USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Alstom SA (ALO):企業の財務・戦略的SWOT分析
    Alstom SA (ALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Broadspectrum (Australia) Pty Ltd:企業の戦略的SWOT分析
    Broadspectrum (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Mitsubishi Heavy Industries, Ltd.:企業の戦略・SWOT・財務情報
    Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Shanghai Zhenhua Heavy Industries Co., Ltd.:企業の戦略・SWOT・財務情報
    Shanghai Zhenhua Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shanghai Zhenhua Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Dampier Gold Limited:企業の戦略・SWOT・財務情報
    Dampier Gold Limited - Strategy, SWOT and Corporate Finance Report Summary Dampier Gold Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Invion Ltd (IVX)-製薬・医療分野:企業M&A・提携分析
    Summary Invion Ltd (Invion) is a life sciences company that develops products for the treatment of inflammatory diseases such as chronic inflammatory, airway disease and inflammation caused by autoimmune disease. The company's pipeline products include INV102 nadolol, a beta blocker for inflammatory …
  • Statewide Superannuation Pty Ltd:企業の戦略的SWOT分析
    Statewide Superannuation Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Tennant Co (TNC):企業の財務・戦略的SWOT分析
    Tennant Co (TNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Coloplast AS (COLO B):企業の財務・戦略的SWOT分析
    Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Save The Children Federation Inc:企業の戦略的SWOT分析
    Save The Children Federation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • BC Hydro-エネルギー分野:企業M&A・提携分析
    Summary BC Hydro (BC) is a government-owned hydroelectric utility company that generates, distributes and supply power. It is a provincial Crown corporation owned by the Province of British Columbia. Through its subsidiary, Powerex, it buys and sells wholesale power, renewable energy, financial ener …
  • HCL Technologies Ltd (HCLTECH):企業の財務・戦略的SWOT分析
    HCL Technologies Ltd (HCLTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • SRF Ltd (SRF):企業の財務・戦略的SWOT分析
    SRF Ltd (SRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Duke University Health System Inc:企業の戦略的SWOT分析
    Duke University Health System Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • ING-DiBa AG:企業の戦略的SWOT分析
    ING-DiBa AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • L’Oreal SA:戦略・SWOT・企業財務分析
    L'Oreal SA - Strategy, SWOT and Corporate Finance Report Summary L'Oreal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Toei Animation Co., Ltd.:企業の戦略・SWOT・財務分析
    Toei Animation Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toei Animation Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Vesteda Group:企業の戦略・SWOT・財務情報
    Vesteda Group - Strategy, SWOT and Corporate Finance Report Summary Vesteda Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • nLife Therapeutics SL-製薬・医療分野:企業M&A・提携分析
    Summary nLife Therapeutics SL (nLife Therapeutics) is a biopharmaceutical company that discovers and develops proprietary neuronal specific oligonucleotides as therapeutic agents for the treatment of central nervous system disorders. Its lead candidate NLF-PD-1233 is a first in class oligonucleotide …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆